Base Editing Gene Therapy Restores Hearing in Mice
In the first example of repairing a recessive gene mutation, base editors have treated a mouse model of genetic deafness, restoring partial hearing.
Related Articles
Immunotherapy Safely Boosted with Particle-Bound Cytokines in Tumor Models
Used in combination with immune checkpoint therapy, cytokine molecules “step on the gas” to jump-start the immune system’s anticancer response.
Boehringer Ingelheim, Ochre Bio Launch Up-to-$1B+ Liver Disease Partnership
Boehringer Ingelheim will apply Ochre Bio’s discovery platform to develop treatments for late-stage metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis and other chronic liver diseases (CLDs), through…
Exploring Brain Cell Mapping via AI but without Coding Expertise
Scientists maintain that findings from using DELiVR have revealed potential therapeutic targets within brain regions.
Combatting Muscle Loss in Aging
A new study shows that increased levels of a protein named TP53INP2 in muscle correlate with greater muscular strength and healthier aging in humans.
Online Event
The interest in the use of organoids to model human development in health and disease is at an all-time high. Recently, a team from the…
Boehringer Ingelheim, Ochre Bio Launch Up-to-$1B+ Liver Disease Partnership
Boehringer Ingelheim will apply Ochre Bio’s discovery platform to develop treatments for late-stage metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis and other chronic liver diseases (CLDs), through…
Aspirin Appears to Protect against Colon Cancer by Boosting Immunosurveillance
Findings suggest regular aspirin use may have an active role in enhancing Immunosurveillance against colorectal cancer.
Immunotherapy Safely Boosted with Particle-Bound Cytokines in Tumor Models
Used in combination with immune checkpoint therapy, cytokine molecules “step on the gas” to jump-start the immune system’s anticancer response.
StockWatch: PacBio Faces Uphill Climb as Q1 Revenue Falls Short
PacBio shares plummeted 51% on Tuesday, after it reversed its earlier “guidance” forecast to investors for 5% operating expense growth this year, revealing instead plans…
Assembloids Model Patient-Specific Lung Cancers with Tumor Microenvironments
The lung cancer assembloid model can predict personalized treatments and has the potential to drive personalized lung cancer therapies.